Long-Term Liabilities: The sum of all non-current liabilities.
Aura Biosciences, Inc. (AURA) had Long-Term Liabilities of $13.30M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-45.64M |
|
-- |
|
-- |
|
$48.07M |
|
$-48.07M |
|
$2.46M |
|
$-45.61M |
|
$-45.61M |
|
$-45.64M |
|
$-45.64M |
|
$-45.64M |
|
$-45.64M |
|
$-48.07M |
|
$-47.81M |
|
94.86M |
|
94.86M |
|
$-0.48 |
|
$-0.48 |
|
| Balance Sheet Financials | |
$329.03M |
|
$2.20M |
|
$19.10M |
|
$348.13M |
|
$19.56M |
|
-- |
|
|
Long-Term Liabilities |
$13.30M |
$32.86M |
|
$315.27M |
|
$315.27M |
|
$315.27M |
|
103.48M |
|
| Cash Flow Statement Financials | |
$-62.39M |
|
$-171.14M |
|
$242.05M |
|
$60.28M |
|
$68.60M |
|
$8.32M |
|
$16.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-62.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-14.48% |
|
-14.48% |
|
-13.11% |
|
-14.48% |
|
$3.05 |
|
$-0.66 |
|
$-0.66 |
|